Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Active Ester Activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel active ester route for Ivabradine intermediate eliminates thionyl chloride hazards. Improves yield to 80 percent ensuring robust supply chain stability.
Patent CN112209859B reveals a safer CDI-based route for Iguratimod intermediates, offering high purity and reduced operational hazards for API manufacturing.